A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a randomized, Open-label, Phase Ib/IIa study to evaluate the efficacy and safety of SPH4336 monotherapy or in combination with Cadonilimab in the patients with selected advanced solid tumors.
Epistemonikos ID: a3474fb545b02a6678c0d0ad1193aa1b1c3fd647
First added on: May 15, 2024